Case Report: Polymyxin E-associated reversible leukopenia
These findings suggest that polymyxin E likely induces leukopenia, emphasizing the need for rigorous WBC monitoring during treatment and prompt discontinuation when hematologic abnormalities emerge to minimize patient health risks.
Authors
- Jiaquan Zhu (ORCID: https://orcid.org/0000-0002-9250-4366)
- Lihua Wang (ORCID: https://orcid.org/0000-0002-6198-7561)
- Suxin Wan
Institutions
- Chongqing Three Gorges Central Hospital (CN)
- Chongqing Medical and Pharmaceutical College (CN)
- Chongqing Three Gorges University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-08-14
- DOI
- https://doi.org/10.3389/fimmu.2025.1537972
- Citations
- 2
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.63